(secondQuint)Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1.

 Starting on Day 1 and for up to 12 weeks, you will receive Telaprevir (TVR) and Sofosbuvir (SOF).

 You will take one (1) 400 mg tablet of SOF and 3 tablets (1125 mg each) of TVR.

 You should take these together by mouth every morning.

 You will take another 3 tablets (1125 mg each) of TVR by mouth 12 hours after you take your morning dose.

.

 Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1@highlight

This is an open-label, multi center study of treatment-naive non-cirrhotic subjects with genotype 1 chronic Hepatitis C Virus.

 All subjects will receive telaprevir (TVR) in combination with sofosbuvir (SOF) for 12 weeks.

